Published in Eur J Neurol on November 05, 2014
Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol (2015) 1.71
Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci (2015) 1.10
Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interaction. Eur J Neurol (2015) 0.76
Applying Systems Biology Methodology To Identify Genetic Factors Possibly Associated with Recovery after Traumatic Brain Injury. J Neurotrauma (2017) 0.75
What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology (1992) 6.03
Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet (2012) 4.27
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet (2001) 2.52
Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol (2005) 2.40
Clinical characteristics in early Parkinson's disease in a central California population-based study. Mov Disord (2005) 2.19
alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet (2001) 2.07
alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol (2004) 1.97
Closed head injury--an inflammatory disease? Brain Res Brain Res Rev (2005) 1.91
Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol (2003) 1.89
alpha-Synuclein and Parkinson disease susceptibility. Neurology (2007) 1.72
Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med (2007) 1.60
Genetic association between alpha-synuclein and idiopathic Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 1.50
Protein accumulation in traumatic brain injury. Neuromolecular Med (2003) 1.41
Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet (2003) 1.38
α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease. PLoS One (2012) 1.33
Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Acta Neurol Scand (2008) 1.21
Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord (2013) 1.21
α-Synuclein in CSF of patients with severe traumatic brain injury. Neurology (2013) 1.20
Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease. Neurology (2012) 1.17
Head injury, α-synuclein Rep1, and Parkinson's disease. Ann Neurol (2012) 1.14
The effect of SNCA 3' region on the levels of SNCA-112 splicing variant. Neurogenetics (2010) 1.03
Are prisoners reliable survey respondents? A validation of self-reported traumatic brain injury (TBI) against hospital medical records. Brain Inj (2010) 0.98
alpha-Synuclein locus triplication causes Parkinson's disease. Science (2003) 20.20
Bayesian selection of continuous-time Markov chain evolutionary models. Mol Biol Evol (2001) 8.69
alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. J Neurosci (1999) 2.25
In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol (1996) 2.22
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med (1998) 2.20
The CALM1 core promoter polymorphism is not associated with hip osteoarthritis in a United Kingdom Caucasian population. Osteoarthritis Cartilage (2005) 1.99
Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet (2001) 1.95
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol (2011) 1.90
Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology (2009) 1.86
Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p. Acta Neuropathol (2000) 1.79
alpha-Synuclein and Parkinson disease susceptibility. Neurology (2007) 1.72
Widespread alterations of alpha-synuclein in multiple system atrophy. Am J Pathol (1999) 1.65
Genetic influences in end-stage osteoarthritis. Sibling risks of hip and knee replacement for idiopathic osteoarthritis. J Bone Joint Surg Br (1997) 1.60
Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart (2001) 1.60
Familial associations of Alzheimer disease and essential tremor with Parkinson disease. Eur J Neurol (2010) 1.56
Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter. Neurobiol Dis (2001) 1.48
Lower cardiac mortality in smokers following thrombolysis for acute myocardial infarction may be related to more effective fibrinolysis. QJM (1999) 1.41
Inequalities and health. Lancet (1994) 1.40
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology (2000) 1.31
Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet (2010) 1.29
Anatomical localization of leucine-rich repeat kinase 2 in mouse brain. Neuroscience (2006) 1.28
Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet (1999) 1.27
Occurrence of depression and anxiety prior to Parkinson's disease. Parkinsonism Relat Disord (2010) 1.23
Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes. Heart (1997) 1.20
Respiratory diseases and allergies in two polluted areas in East Germany. Environ Health Perspect (1999) 1.19
Penalized regression for genome-wide association screening of sequence data. Pac Symp Biocomput (2011) 1.17
Computational advances in maximum likelihood methods for molecular phylogeny. Genome Res (1998) 1.15
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Solution structure of a complex between [N-MeCys3,N-MeCys7]TANDEM and [d(GATATC)]2. Biochemistry (1993) 1.13
Estimation of neonatal outcome and perinatal therapy use. Pediatrics (2000) 1.12
Linkage analysis of chromosome 2q in osteoarthritis. Rheumatology (Oxford) (2000) 1.11
Association analysis of the vitamin D receptor gene, the type I collagen gene COL1A1, and the estrogen receptor gene in idiopathic osteoarthritis. J Rheumatol (2000) 1.08
General practitioners' views on genetic screening for common diseases. Br J Gen Pract (1999) 1.05
Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family. Parkinsonism Relat Disord (2008) 1.04
Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Parkinson's disease. Neuroreport (1999) 1.04
End-stage coxarthrosis and gonarthrosis. Aetiology, clinical patterns and radiological features of idiopathic osteoarthritis. Rheumatology (Oxford) (2000) 1.04
Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Arch Gen Psychiatry (1997) 1.02
Calculation of genetic identity coefficients. Ann Hum Genet (1992) 1.01
Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol (2001) 1.01
The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. Neurosci Lett (2005) 1.00
Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark. Eur J Neurol (2012) 1.00
Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res (2001) 0.98
Pathology of PD in monozygotic twins with a 20-year discordance interval. Neurology (2001) 0.98
SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology (2002) 0.98
A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology (2005) 0.97
Fishing for pleiotropic QTLs in a polygenic sea. Ann Hum Genet (2005) 0.97
Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology (2005) 0.96
Localization of frontotemporal dementia with parkinsonism in an Australian kindred to chromosome 17q21-22. Ann Neurol (1997) 0.95
Gas cooking, respiratory health and white blood cell counts in children. Int J Hyg Environ Health (2000) 0.94
No pathogenic mutations in the beta-synuclein gene in Parkinson's disease. Neurosci Lett (1999) 0.94
Linkage analysis of candidate genes as susceptibility loci for osteoarthritis-suggestive linkage of COL9A1 to female hip osteoarthritis. Rheumatology (Oxford) (2000) 0.94
Refinement of the PARK3 locus on chromosome 2p13 and the analysis of 14 candidate genes. Eur J Hum Genet (2001) 0.93
LRRK2 mutations are a common cause of Parkinson's disease in Spain. Eur J Neurol (2006) 0.92
Estimated effects of disinfection by-products on birth weight in a population served by a single water utility. Am J Epidemiol (2005) 0.92
Impact of first myocardial infarction on self-perceived health status. QJM (2001) 0.92
Structure and stability of X.G.C mismatches in the third strand of intramolecular triplexes. Science (1991) 0.91
No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet (1999) 0.90
Psychosocial risk factors, pre-motor symptoms and first-time hospitalization with Parkinson's disease: a prospective cohort study. Eur J Neurol (2013) 0.89
Comparison of perceived and actual rates of survival and freedom from handicap in premature infants. Am J Obstet Gynecol (1994) 0.89
Bed rest in pregnancy. Obstet Gynecol (1994) 0.88
Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. Neurology (2003) 0.87
Patient-related outcomes five years after coronary artery bypass graft surgery. QJM (1999) 0.87
A kindred with Parkinson's disease not showing genetic linkage to established loci. Neurology (2000) 0.87
Estimation of outcome and restriction of interventions in neonates. Pediatrics (1998) 0.87
Utilization of dental sealants by Alabama Medicaid children: barriers in meeting the year 2010 objectives. Pediatr Dent (2001) 0.84
Quantifying risks of preterm birth in the Arkansas Medicaid population, 2001-2005. J Perinatol (2011) 0.84
Genetic association analysis of LRCH1 as an osteoarthritis susceptibility locus. Rheumatology (Oxford) (2006) 0.83
Decreased CD8 cell-mediated viral suppression and other immunologic characteristics of women who transmit human immunodeficiency virus to their infants. J Infect Dis (1999) 0.83
A comparison of measurements of lean body mass derived by bioelectrical impedance, skinfold thickness and total body potassium. A study in obese and non-obese normal subjects. Scand J Clin Lab Invest (1991) 0.83
The effect of low-level blood lead on hematologic parameters in children. Environ Res (2000) 0.82
A multi-incident, Old-Order Amish family with PD. Neurology (2002) 0.82
SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene: analysis of Nigerian family data using gamete competition models. Ann Hum Genet (2005) 0.82
Primate DAX1, SRY, and SOX9: evolutionary stratification of sex-determination pathway. Am J Hum Genet (2000) 0.82
Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL. Mamm Genome (2001) 0.82
Identification and characterization of the human parkin gene promoter. J Neurochem (2001) 0.81
Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci (2011) 0.81
Mutation takes no vacation: can structured treatment interruptions increase the risk of drug-resistant HIV-1? J Acquir Immune Defic Syndr (2000) 0.81
New parkin mutations and atypical phenotypes in families with autosomal recessive parkinsonism. Neurology (2003) 0.81
A double blind study of the effect of acipimox on serum lipids, blood glucose control and insulin action in non-obese patients with type 2 diabetes mellitus. Diabet Med (1992) 0.81
Risk factor control five years after coronary bypass grafting. J R Coll Physicians Lond (1996) 0.81
Major life events and development of major depression in Parkinson's disease patients. Eur J Neurol (2012) 0.81
Low prenatal weight gain among adult WIC participants delivering term singleton infants: variation by maternal and program participation characteristics. Matern Child Health J (1999) 0.81
The SON gene encodes a conserved DNA binding protein mapping to human chromosome 21. Ann Hum Genet (1994) 0.81
No pathogenic mutations in the persyn gene in Parkinson's disease. Neurosci Lett (1999) 0.81
Sensitization of neuronal cells to oxidative stress with mutated human alpha-synuclein. J Neurochem (2000) 0.80
Incorporating serotypes into family based association studies using the MFG test. Ann Hum Genet (2006) 0.80
Physician opinions of preterm infant outcome and their effect on antenatal corticosteroid use. J Perinatol (1997) 0.80
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancer. Clin Cancer Res (1998) 0.80
Consanguinity and relative-pair methods for linkage analysis. Am J Hum Genet (1998) 0.80
Pharmacists as HIV/AIDS information resources: survey of Alabama pharmacists. AIDS Educ Prev (1995) 0.80
[Platypnea-orthodeoxia syndrome: case report]. Ann Cardiol Angeiol (Paris) (2013) 0.79
Flosequinan and arrhythmogenesis. Lancet (1993) 0.79
Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery. Heart (1997) 0.79
The effect of entacapone on homocysteine levels in Parkinson disease. Neurology (2005) 0.78
Reproductive factors and Parkinson's disease risk in Danish women. Eur J Neurol (2014) 0.78
Two large British kindreds with familial Parkinson's disease: a clinico-pathological and genetic study. Brain (2002) 0.78